— Know what they know.
Not Investment Advice

MYO AMEX

Myomo, Inc.
1W: +0.0% 1M: +14.2% 3M: +40.0% YTD: +62.6% 1Y: +75.9% 3Y: +36.4% 5Y: -87.3%
$1.63
+0.02 (+1.24%)
 
Weekly Expected Move ±9.1%
$1 $1 $2 $2 $2
AMEX · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 71 · $63.0M mcap · 35M float · 2.16% daily turnover · Short 45% of daily vol
Smart Money Score
Moderate 50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$63.0M
52W Range0.605-1.89
Volume171,786
Avg Volume760,005
Beta1.50
Dividend—
Analyst Ratings
7 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOPaul R. Gudonis
Employees195
SectorHealthcare
IndustryMedical - Devices
IPO Date2017-06-12
Websitemyomo.com
45 Blue Sky Dr.
Burlington, MA 01803
US
617 996 9058
About Myomo, Inc.

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Kovelman Harry S-Sale 15,488 $1.27 2026-09-11
Morris Milton Mayo S-Sale 15,000 $1.41 2026-09-02
Kovelman Harry S-Sale 17,500 $1.73 2026-08-20
Kovelman Harry S-Sale 17,250 $1.73 2026-08-20
GUDONIS PAUL R A-Award 146,909 — 2026-08-07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms